For this purpose, we employed five serum biological markers (TGF-β1, collagen IV, MMP-2, laminin and EGF-R) which are assumed to reflect the degree of liver fibrosis and compared these markers in 50 pediatric patients with chronic liver diseases to 30 healthy controls. This evidence concerns the gene TGFB1 and Hepatic fibrosis.